DARA Biosciences Announces Distribution Deal for Gelclair(R), Soltamox(R)

DARA BioSciences, Inc. DARA, a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today that it has signed an agreement with Prime Therapeutics Specialty Pharmacy LLC for distribution of its two lead proprietary products, Gelclair® (oral bioadhesive gel) for patients with oral mucositis and Soltamox® (tamoxifen citrate) oral solution to treat breast cancer patients.